CEP55 promotes epithelial–mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway

被引：0
|
作者：
H. Chen
D. Zhu
Z. Zheng
Y. Cai
Z. Chen
W. Xie
机构：
[1] Sun Yat-sen University,Department of Urology, Sun Yat
[2] Sun Yat-sen University,sen Memorial Hospital
来源：
Clinical and Translational Oncology | 2019年 / 21卷
关键词：
Renal cell carcinoma; CEP55; Epithelial–mesenchymal transition; Proliferation; Metastasis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：939 / 949
页数：10
相关论文
共 50 条
  • [21] YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition
    Luo, Xiangyuan
    Cao, Mengdie
    Gao, Fan
    He, Xingxing
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2021, 10 (01)
  • [22] YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition
    Xiangyuan Luo
    Mengdie Cao
    Fan Gao
    Xingxing He
    Experimental Hematology & Oncology, 10
  • [23] COPS8 promotes hepatocellular carcinoma progression through the PI3K/AKT/mTOR pathway
    Yan, Xiaodong
    Li, Zhongmin
    Tian, Qing
    Zhang, Yamin
    ASIAN JOURNAL OF SURGERY, 2024, 47 (06) : 2947 - 2949
  • [24] CAV2 promotes the growth of renal cell carcinoma through the EGFR/PI3K/Akt pathway
    Liu, Fu
    Zhi Shangli
    Hu, Zhili
    ONCOTARGETS AND THERAPY, 2018, 11 : 6209 - 6216
  • [25] Arctigenin inhibits the progression of colorectal cancer through epithelial-mesenchymal transition via PI3K/Akt/mTOR signaling pathway
    Chen, Xiang-Fan
    Liu, Pei-Gen
    Sheng, Nan
    Li, Xin-Shuai
    Hu, Rui-Kun
    Zhu, Long-Xun
    Feng, Panfeng
    PLOS ONE, 2024, 19 (09):
  • [26] Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway
    Miao, Lifeng
    Jiang, Zheng
    Wang, Jiwei
    Yang, Ning
    Qi, Qichao
    Zhou, Wenjing
    Feng, Zichao
    Li, Wenjie
    Zhang, Qing
    Huang, Bin
    Chen, Anjing
    Zhang, Di
    Zhao, Peng
    Li, Xingang
    ONCOLOGY REPORTS, 2019, 42 (02) : 605 - 614
  • [27] IMMT promotes hepatocellular carcinoma formation via PI3K/AKT/mTOR pathway
    Wang, Jiabei
    Zhang, Yunguang
    Sun, Linmao
    Liu, Yao
    ONCOLOGIE, 2023, 25 (06) : 691 - 703
  • [28] Angelica Sinensis promotes myotube hypertrophy through the PI3K/Akt/mTOR pathway
    Yeh, Tzu-Shao
    Hsu, Cheng-Chen
    Yang, Suh-Ching
    Hsu, Mei-Chich
    Liu, Jen-Fang
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2014, 14
  • [29] Angelica Sinensis promotes myotube hypertrophy through the PI3K/Akt/mTOR pathway
    Tzu-Shao Yeh
    Cheng-Chen Hsu
    Suh-Ching Yang
    Mei-Chich Hsu
    Jen-Fang Liu
    BMC Complementary and Alternative Medicine, 14
  • [30] Targeting the PI3K/AKT/mTOR pathway in cutaneous squamous cell carcinoma
    Perry, Jay Ryan
    Thind, Amarinder Singh
    Minaei, Elahe
    Ryan, Emily
    Genenger, Benjamin
    Iyer, Gopal
    Martin, Carolan
    Ashford, Bruce
    Ranson, Andmarie
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 43 - 43
12345